First Time Loading...

Gilead Sciences Inc
NASDAQ:GILD

Watchlist Manager
Gilead Sciences Inc Logo
Gilead Sciences Inc
NASDAQ:GILD
Watchlist
Price: 64.27 USD 0.3% Market Closed
Updated: Jun 1, 2024

Gilead Sciences Inc
Other Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Gilead Sciences Inc
Other Liabilities Peer Comparison

Comparables:
ABBV
AMGN
MRNA
VRTX
REGN

Competitive Other Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Other Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Gilead Sciences Inc
NASDAQ:GILD
Other Liabilities
$3.4B
CAGR 3-Years
-20%
CAGR 5-Years
-14%
CAGR 10-Years
24%
Abbvie Inc
NYSE:ABBV
Other Liabilities
$32.8B
CAGR 3-Years
7%
CAGR 5-Years
18%
CAGR 10-Years
26%
Amgen Inc
NASDAQ:AMGN
Other Liabilities
$6.3B
CAGR 3-Years
-12%
CAGR 5-Years
-9%
CAGR 10-Years
0%
Moderna Inc
NASDAQ:MRNA
Other Liabilities
$957m
CAGR 3-Years
51%
CAGR 5-Years
42%
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Other Liabilities
$1.2B
CAGR 3-Years
23%
CAGR 5-Years
51%
CAGR 10-Years
33%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Other Liabilities
$1.1B
CAGR 3-Years
22%
CAGR 5-Years
-2%
CAGR 10-Years
18%

See Also

What is Gilead Sciences Inc's Other Liabilities?
Other Liabilities
3.4B USD

Based on the financial report for Mar 31, 2024, Gilead Sciences Inc's Other Liabilities amounts to 3.4B USD.

What is Gilead Sciences Inc's Other Liabilities growth rate?
Other Liabilities CAGR 10Y
24%

Over the last year, the Other Liabilities growth was -33%. The average annual Other Liabilities growth rates for Gilead Sciences Inc have been -20% over the past three years , -14% over the past five years , and 24% over the past ten years .